01 February 2007 By:
Diana Marjanovic, Gerhard Greller
|
Over the past decade, disposable technologies have become a reality in biotech processes. The use of disposables in research and manufacturing allows high flexibility.

01 February 2007 By:
Diana Marjanovic, Gerhard Greller
|
Over the past decade, disposable technologies have become a reality in biotech processes. The use of disposables in research and manufacturing allows high flexibility.

01 February 2007 By:
Diana Marjanovic, Gerhard Greller
|
Over the past decade, disposable technologies have become a reality in biotech processes. The use of disposables in research and manufacturing allows high flexibility.

01 November 2006 By:
Manuel A.del Valle
|
Clean rooms are critical areas in bio/pharma facilities, and it is essential that users are responsible for their care and upkeep, and familiarize themselves with the relevant regulations.

01 November 2006 By:
Simon Moroney
|
The ¤9.5 billion therapeutic antibody market comprises over a dozen antibodies that have been generated using recombinant genetic methods developed over the last 20 years.

01 November 2006 By:
Manuel A.del Valle
|
Clean rooms are critical areas in bio/pharma facilities, and it is essential that users are responsible for their care and upkeep, and familiarize themselves with the relevant regulations.

01 October 2006 By:
Louis Rey, Florence Lhospice
|
In view of the nature of its complexity, it might be desirable to apply FDA's process analytical technology to lyophilization.

01 October 2006 By:
Sir Keith O'Nions
|
UK science has an outstanding record and we remain strong internationally in terms of achievement, productivity and efficiency.

01 October 2006 By:
Sir Keith O'Nions
|
UK science has an outstanding record and we remain strong internationally in terms of achievement, productivity and efficiency.
